HBSAg Proteins
| Catalog no. | Product | Reactivity | Host / Clonality | Application | Price & lead time |
|---|---|---|---|---|---|
| HBSAg Protein (AA 2-119) (Fc Tag) | Hepatitis B Virus (HBV) | Mammalian Cells |
|
$372.52
View price
|
|
| HBSAg Protein-VLP (Subtype adw) | Hepatitis B Virus (HBV) | Yeast (Hansenula) |
|
$346.15
View price
|
|
| HBSAg Protein (Subtype adw) | Hepatitis B Virus (HBV) | Hepatitis B Virus (HBV) |
$604.95
View price
|
||
| HBSAg Protein (Subtype adr) | Hepatitis B Virus (HBV) | Yeast |
|
$1,320.46
View price
|
|
| HBSAg Protein (Subtype ay) | Hepatitis B Virus (HBV) | Yeast (Saccharomyces Cerevisiae) |
|
$619.36
View price
|
|
| HBSAg Protein (Subtype ad) | Hepatitis B Virus (HBV) | Human |
|
$510.34
View price
|
|
| HBSAg Protein (Subtype adw) | Hepatitis B Virus (HBV) | – |
|
$2,429.73
View price
|
|
| HBSAg Protein (Subtype ay) | Hepatitis B Virus (HBV) | Human |
|
$1,199.66
View price
|
|
| HBSAg Protein (Subtype ay) | Hepatitis B Virus (HBV) | Human |
|
$510.34
View price
|
|
| HBSAg Protein (Subtype ayw) | Hepatitis B Virus (HBV) | Yeast (Pichia pastoris) |
|
$1,324.40
View price
|
|
| HBSAg Protein (Subtype adr) | Hepatitis B Virus (HBV) | CHO Cells |
|
$1,917.30
View price
|
|
| HBSAg Protein (Subtype adw) | Hepatitis B Virus (HBV) | Yeast (Saccharomyces Cerevisiae) |
|
$1,156.54
View price
|
|
| HBSAg Protein (Subtype ad) | Hepatitis B Virus (HBV) | CHO Cells |
|
$401.28
View price
|
|
| HBSAg Protein (Subtype ad) | Hepatitis B Virus (HBV) | Human |
|
$1,534.50
View price
|
|
| HBSAg Protein (Subtype ay) | Hepatitis B Virus (HBV) | Yeast (Saccharomyces Cerevisiae) |
|
$1,275.12
View price
|
|
| HBSAg Protein (Subtype ad) | Hepatitis B Virus (HBV) | Yeast (Saccharomyces Cerevisiae) |
|
$1,275.12
View price
|
|
| HBSAg Protein (Subtype ad) | Hepatitis B Virus (HBV) | Human |
|
$3,788.40
View price
|
|
| HBSAg Protein (AA 56-281) | Hepatitis B Virus (HBV) | Yeast (Pichia pastoris) |
|
$2,629.97
View price
|
|
| HBSAg Protein (Subtype adw) | Hepatitis B Virus (HBV) | Yeast |
|
$2,089.66
View price
|
|
| HBSAg Protein (Subtype ay) | Hepatitis B Virus (HBV) | Yeast |
|
$2,012.66
View price
|
- SDS (SDS-PAGE: Validation image available)
- ELISA (ELISA: Validation image available)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Mammalian Cells
- Protein Type
- Recombinant
- Purity
- The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
- TEM (Transmission electron microscopy: Validation image available)
- ELISA (ELISA: Listed application)
- WB (Western Blotting: Listed application)
- SDS (SDS-PAGE: Listed application)
- Grade
- Animal-Free
- Origin
- Hepatitis B Virus (HBV)
- Host
- Yeast (Hansenula)
- Protein Type
- VLP
- Purity
- > 95 % (SDS-PAGE)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Hepatitis B Virus (HBV)
- Protein Type
- Native
- Purity
- > 95 % pure
- ELISA (ELISA: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Yeast
- Protein Type
- Recombinant
- Purity
- > 95 % pure
- ELISA (ELISA: Listed application)
- WB (Western Blotting: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Yeast (Saccharomyces Cerevisiae)
- Protein Type
- Recombinant
- Purity
- 95 % by SDS-PAGE
- Origin
- Hepatitis B Virus (HBV)
- Host
- Human
- Protein Type
- Native
- Purity
- > 99 % (ELISA)
- BCA (Biochemical Assay: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Protein Type
- Recombinant
- EIA (Enzyme Immunoassay: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Human
- Origin
- Hepatitis B Virus (HBV)
- Host
- Human
- Protein Type
- Native
- Purity
- > 98 %
- WB (Western Blotting: Listed application)
- EIA (Enzyme Immunoassay: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Yeast (Pichia pastoris)
- Protein Type
- Recombinant
- EIA (Enzyme Immunoassay: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- CHO Cells
- Protein Type
- Recombinant
- EIA (Enzyme Immunoassay: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Yeast (Saccharomyces Cerevisiae)
- Protein Type
- Recombinant
- Purity
- > 98 %
- ELISA (ELISA: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- CHO Cells
- Protein Type
- Recombinant
- Purity
- >90 %
- ELISA (ELISA: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Human
- Protein Type
- Native
- Purity
- >95 %
- Biological Activity
- Inactive
- WB (Western Blotting: Listed application)
- EIA (Enzyme Immunoassay: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Yeast (Saccharomyces Cerevisiae)
- Protein Type
- Recombinant
- WB (Western Blotting: Listed application)
- EIA (Enzyme Immunoassay: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Yeast (Saccharomyces Cerevisiae)
- Protein Type
- Recombinant
- EIA (Enzyme Immunoassay: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Human
- Protein Type
- Native
- Purity
- > 99 % “Ad” subtype purity (ELISA)
- ELISA (ELISA: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Yeast (Pichia pastoris)
- Protein Type
- Recombinant
- ELISA (ELISA: Listed application)
- WB (Western Blotting: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Yeast
- Protein Type
- Recombinant
- ELISA (ELISA: Listed application)
- Origin
- Hepatitis B Virus (HBV)
- Host
- Yeast
- Protein Type
- Recombinant
Latest Publications for our HBSAg Proteins
: "Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis." in: PLoS ONE, Vol. 11, Issue 12, pp. e0167757, (2017) (PubMed).
: "Induction of Strong and Specific Humoral and T-helper 1 Cellular Responses by HBsAg Entrapped in the Methanobrevibacter smithii Archaeosomes." in: Avicenna journal of medical biotechnology, Vol. 6, Issue 4, pp. 238-45, (2014) (PubMed).
: "Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-? therapy during pregnancy: three-center study." in: Scandinavian journal of gastroenterology, Vol. 48, Issue 8, pp. 951-8, (2013) (PubMed).
: "Synergetic chemiluminescence and label-free dual detection for developing a hepatitis protein array." in: Journal of immunological methods, Vol. 371, Issue 1-2, pp. 159-64, (2011) (PubMed).
: "Elevated serum IgE prior to acute severe infusion reaction during infliximab maintenance therapy in a Crohn's disease patient." in: Inflammatory bowel diseases, Vol. 17, Issue 12, pp. E156-7, (2011) (PubMed).
: "Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination." in: Vaccine, Vol. 28, Issue 21, pp. 3672-8, (2010) (PubMed).
: "Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine." in: Antiviral research, Vol. 42, Issue 2, pp. 97-108, (1999) (PubMed).
Did you look for something else?
- HBS1L Proteins
- HBQ1 Proteins
- HBP1 Proteins
- HBG2 Proteins
- HBG1 Proteins
- HBEGF Proteins
- HBd Proteins
- HbA1c Proteins
- HBA1 Proteins
- HAX1 Proteins
- HAUS7 Proteins
- HAUS2 Proteins
- HAUS1 Proteins
- HAT1 Proteins
- HAS3 Proteins
- HAS2 Proteins
- HAS1 Proteins
- HARS2 Proteins
- HARS1/Jo-1 Proteins
- HARBI1 Proteins
- HBXIP Proteins
- HBZ Proteins
- HCCS Proteins
- HCFC1 Proteins
- HCFC1R1 Proteins
- HCFC2 Proteins
- HCK Proteins
- HCLS1 Proteins
- HCN1 Proteins
- HCN2 Proteins
- HCN3 Proteins
- HCN4 Proteins
- HCRTR1 Proteins
- HCRTR2 Proteins
- HCST Proteins
- HCV Core Protein Proteins
- HCV E2 Proteins
- HCV NS3 Proteins
- HDAC1 Proteins
- HDAC10 Proteins